Microbiome Company Kaleido Biosciences Announces $120 Million IPO

On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of  common stock. The expected price is between $20 and $22 per share. The shares will be listed on NASDAQ under the symbol, “KLDO.”